[Gestational diabetes--perinatal hyperinsulinism and postnatal developmental disorders]

Area of Science:

• Endocrinology
• Maternal-Fetal Medicine
• Public Health

Background:

• Impaired glucose tolerance in pregnancy (IGT) is linked to fetal hyperinsulinism, increasing risks for insulin-dependent diabetes mellitus (IDDM), non-insulin-dependent diabetes (NIDDM), obesity, and cardiovascular diseases.
• Prospective studies on newborns of diabetic mothers are challenging due to fragmented healthcare management.
• Current preventive strategies often overlook the importance of gestational diabetes screening for reducing long-term morbidity.

Purpose of the Study:

• To advocate for universal glucose screening during pregnancy.
• To investigate the long-term developmental outcomes of newborns.
• To emphasize the role of maternal glycemic control in preventing future health issues.

Main Methods:

• Review of existing literature on impaired glucose tolerance in pregnancy and its long-term effects.
• Analysis of the relationship between maternal glycemia and neonatal health.
• Evaluation of the impact of glycosylated hemoglobin and amniotic fluid insulin levels.

Main Results:

• Maternal hyperglycemia during pregnancy is a significant determinant of neonatal health and later-life morbidity.
• The quality of maternal glycemic control, assessed via HbA1c and amniotic fluid insulin, influences neonatal outcomes.
• Lack of comprehensive gestational diabetes screening limits preventive potential.

Conclusions:

• Implementing general glucose screening in pregnancy is essential for early detection and management of IGT.
• Improved maternal glycemic control can mitigate neonatal risks and reduce the incidence of future metabolic and cardiovascular diseases.
• Proactive screening and management are vital for decreasing the morbidity associated with diabetes and obesity in offspring.